Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Equinox Gold Corp. (EQX-X) announced Mubadala Investment Company has agreed to purchase $130-million in convertible notes from the company. “Proceeds from the investment will be used to refinance a portion of existing corporate and project debt, for general and working capital purposes and toward construction of Phase 1 at Castle Mountain,” the company stated.

**

Story continues below advertisement

North American Construction Group Ltd. (NOA-T; NOA-N) reported fourth-quarter revenue of $131-million, compared to $82-million for the prior year. Adjusted EBITDA was $28.4-million compared to $18.1-million for the prior year.

Net income was $2.7-million or 10 cents per share versus net income of $2.5-million or 9 cents a year earlier. Analysts were expecting revenue of $93.3-million and earnings of 13 cents per share

**

TORC Oil & Gas Ltd. (TOG-T) reported a loss of $24.4-million or 11 cents per share in the fourth quarter versus a loss of $22.7-million or 11 cents a year earlier.

**

48North Cannabis Corp. (NRTH-X) announced it has signed Canada’s “first-ever” letter of intent for outdoor grown cannabis with the Société québécoise du cannabis (SQDC).

Under the agreement, 48North said it will supply 1,200 kilograms of cannabis to the SQDC from its outdoor farm in Brant County, Ont. and 120 kilograms of indoor-grown cannabis from its facilities in Brantford, Ont. and Kirkland Lake, Ont.

Story continues below advertisement

“Outdoor, sun-grown cannabis will be essential to the future of the Canadian cannabis industry and 48North is excited to lead the way,” stated Jeannette VanderMarel, co-CEO of 48North. “Through today’s letter of intent, 48North is taking a meaningful step to respond to market demand and provide a reliable and environmentally-sustainable source of production for Quebec.”

**

Australis Capital Inc. (AUSA-C) has acquired Mr. Natural Productions, Inc., a medical and recreational cannabis brand based in California. "This acquisition includes the rights to the Mr. Natural brand, the life story right of Robert Luciano and all related intellectual property, including proprietary processes in a deal valued for US$1.3-million and royalty payments based on future performance incentives, the company stated.

**

Organigram Holdings Inc. (OGI-T), the parent company of Organigram Inc., said it signed a letter of intent with the Société québécoise du cannabis (SQDC) that “solidifies the company’s position as a true national player in Canada’s legal adult use recreational cannabis marketplace.” Organigram said it now has distribution in place for all ten Canadian provinces.

**

Story continues below advertisement

SunOpta Inc. (STKL-Q; SOY-T) reported fourth-quarter revenue of US$320.5-million, an increase of 9.6 per cent compared to US$292.4 million in the fourth quarter of 2017. Its loss attributable to common shareholders for the fourth quarter was US$99-million, or US$1.13 per common share, compared to US$119.4-million, or US $1.38 per common share during the fourth quarter of 2017. Its adjusted loss in the fourth quarter of 2018 was US $9.3-million or 11 cents per common share, compared to US $8.8-million or 10 cents per common share in the fourth quarter of 2017. Analysts were expecting an adjusted loss of 6 cents and revenue $292.9-million

SunOpta also announced the termination of David Colo as president and CEO. Director Katrina L. Houde has been appointed interim CEO.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter